Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28770961http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28770961http://www.w3.org/2000/01/rdf-schema#comment"

Objective

The purpose of this study was to explore the mechanism of microRNA-224 (miR-224) in NSCLC.

Patients and methods

Quantitative RT-PCR (qRT-PCR) was used to evaluate expression levels of miR-224. The association of miR-224 with the clinicopathologic features of NSCLC was evaluated in 56 patients. The roles of miR-224 in cell proliferation were analyzed in vivo and in vitro with pre-miR-224 transfected cells. Also, the regulation of RASSF8 by miR-224 was evaluated by qRT-PCR, Western blotting and luciferase reporter assays.

Results

In this study, we identified miR-224 to be significantly up-regulated in NSCLC tissues and associated with tumor size. Increased miR-224 expression promotes NSCLC cell proliferation by down-regulating RASSF8 at the mRNA and protein levels. The AKT pathway was found aberrantly activated after over-expression of miR-224. RASSF8 was identified as a direct target of miR-224 by bioinformatics analysis and luciferase reporter assay.

Conclusions

The miR-224 played an oncogenic role in the proliferation of NSCLC by direct targeting RASSF8, and it is suggested that miR-224 may be a potential therapeutic target for NSCLC."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/author"Liu W."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/author"Wang L."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/author"Zhang Y.P."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/author"Huang X.R."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/name"Eur Rev Med Pharmacol Sci"xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/pages"3223-3231"xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/title"The miR-224 promotes non-small cell lung cancer cell proliferation by directly targeting RASSF8."xsd:string
http://purl.uniprot.org/citations/28770961http://purl.uniprot.org/core/volume"21"xsd:string
http://purl.uniprot.org/citations/28770961http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28770961
http://purl.uniprot.org/citations/28770961http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28770961
http://purl.uniprot.org/uniprot/#_A8K8G8-mappedCitation-28770961http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/#_Q5SCI0-mappedCitation-28770961http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/#_Q6IB99-mappedCitation-28770961http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/#_Q8NHQ8-mappedCitation-28770961http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/A8K8G8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/Q8NHQ8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/Q5SCI0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28770961
http://purl.uniprot.org/uniprot/Q6IB99http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/28770961